AGC Biologics, a global biopharmaceutical CDMO, has completed the expansion of its manufacturing space at its Milan Cell & Gene Center of Excellence production site. The expansion added 1x50L, 2x200L, 2×1,000L suspension single-use bioreactors, and allows for up to 4 iCellis500 adherent single-use bioreactors to meet demands for upcoming GMP viral vector manufacturing projects. The project also included the build-out of more process development lab space, a new automated filling line an...